1,3-dipropyl-8-cyclopentylxanthine has been researched along with Asystole in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camara, H | 1 |
| da Silva Junior, ED | 1 |
| Garcia, AG | 1 |
| Jurkiewicz, A | 1 |
| Rodrigues, JQD | 1 |
| Chauhan, NK | 1 |
| Young, AM | 1 |
| Gibson, CL | 1 |
| Davidson, C | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Asystole
| Article | Year |
|---|---|
Cardiac arrest induced by muscarinic or adenosine receptors agonists is reversed by DPCPX through double mechanism.
Topics: Adenosine A1 Receptor Agonists; Animals; Carbachol; Heart Arrest; Male; Muscarinic Agonists; Rats; R | 2018 |
Inhibition of pre-ischeamic conditioning in the mouse caudate brain slice by NMDA- or adenosine A1 receptor antagonists.
Topics: Adenosine A1 Receptor Antagonists; Animals; Brain Ischemia; Caudate Nucleus; Dizocilpine Maleate; Do | 2013 |